Current status of projects for developing cancer-related clinical practice guidelines in Japan and recommendations for the future.
Cancers
Clinical practice guidelines
Japan Society of Clinical Oncology
Plan-do-check-act cycle
Journal
International journal of clinical oncology
ISSN: 1437-7772
Titre abrégé: Int J Clin Oncol
Pays: Japan
ID NLM: 9616295
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
02
04
2018
accepted:
17
08
2018
pubmed:
26
8
2018
medline:
14
3
2019
entrez:
26
8
2018
Statut:
ppublish
Résumé
The current status and adoption of cancer-related clinical practice guidelines in Japan has not been elucidated yet. The purpose of this study was to propose roles and suggestions to develop future cancer-related clinical guidelines. A questionnaire consisting of four domains with a total of 17 questions was developed. We distributed the questionnaire to 28 specific academic organizations in Japan which have developed any cancer-related clinical practice guidelines and which were funded by the Ministry of Health, Labor, and Welfare. Most organizations have investigated nationwide dissemination and adoption of clinical practice guidelines. The rate of adoption in clinical practice was estimated at approximately ≥ 70%. However, organizations with smaller budgets reported surveying approximately 60% of the time, whereas the ones with larger budgets reported approximately 100% success in surveying about their guidelines. The presidents of the organizations agreed that a new organization operated directly by the national government was necessary. In Japan, to develop cancer-related clinical practice guidelines, a study of clinical validation is necessary. Sufficient funds must be available to support the project to maintain and revise the guidelines. Furthermore, legal and ethical issues should be solved before establishing any registry system.
Sections du résumé
BACKGROUND
BACKGROUND
The current status and adoption of cancer-related clinical practice guidelines in Japan has not been elucidated yet. The purpose of this study was to propose roles and suggestions to develop future cancer-related clinical guidelines.
METHODS
METHODS
A questionnaire consisting of four domains with a total of 17 questions was developed. We distributed the questionnaire to 28 specific academic organizations in Japan which have developed any cancer-related clinical practice guidelines and which were funded by the Ministry of Health, Labor, and Welfare.
RESULTS
RESULTS
Most organizations have investigated nationwide dissemination and adoption of clinical practice guidelines. The rate of adoption in clinical practice was estimated at approximately ≥ 70%. However, organizations with smaller budgets reported surveying approximately 60% of the time, whereas the ones with larger budgets reported approximately 100% success in surveying about their guidelines. The presidents of the organizations agreed that a new organization operated directly by the national government was necessary.
CONCLUSION
CONCLUSIONS
In Japan, to develop cancer-related clinical practice guidelines, a study of clinical validation is necessary. Sufficient funds must be available to support the project to maintain and revise the guidelines. Furthermore, legal and ethical issues should be solved before establishing any registry system.
Identifiants
pubmed: 30143906
doi: 10.1007/s10147-018-1340-1
pii: 10.1007/s10147-018-1340-1
pmc: PMC6373226
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
189-195Références
Oncology (Williston Park). 2000 Nov;14(11A):26-30
pubmed: 11195417
Int J Clin Oncol. 2010 Jun;15(3):227-33
pubmed: 20333432
PLoS One. 2012;7(11):e49864
pubmed: 23189167
Int J Clin Oncol. 2014 Oct;19(5):771-8
pubmed: 24962287
Lancet. 1993 Nov 27;342(8883):1317-22
pubmed: 7901634
CMAJ. 1997 Jun 15;156(12):1705-12
pubmed: 9220922